LARIMAR THERAPEUTICS INC (LRMR) Stock Cash Flow
NASDAQ:LRMR - Nasdaq - US5171251003 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -64.77M | -36.95M | -35.36M | -50.64M | -42.48M | |||
| Depreciation Amortization | 322.00K | 311.00K | 320.00K | 330.00K | 160.00K | |||
| Change In Working Capital | 2.57M | -2.59M | 1.62M | 2.75M | -2.04M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 3.59M | 5.77M | 5.85M | 5.46M | 2.17M | |||
| OPERATING CASH FLOW | -58.28M | -33.46M | -27.57M | -42.11M | -42.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -164.00K | -100.00K | -330.00K | -60.00K | |||
| Other Investing Activity | -106.71M | 33.52M | -90.86M | 24.50M | 17.15M | |||
| INVESTING CASH FLOW | -107.21M | 33.35M | -90.96M | 24.17M | 17.09M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 161.85M | 30.00K | 75.26M | 19.89M | 75.59M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 18.00M | |||
| FINANCING CASH FLOW | 161.85M | 30.00K | 75.26M | 19.89M | 93.59M | |||
| CHANGE IN CASH | -3.65M | -76.00K | -43.27M | 1.95M | 68.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -58.28M | -33.46M | -27.57M | -42.11M | -42.20M | |||
| Capital Expenditure | N/A | -164.00K | -100.00K | -330.00K | -60.00K | |||
| FREE CASH FLOW | -58.78M | -33.62M | -27.67M | -42.44M | -42.26M | |||
All data in USD